3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
51
Prostatic Neoplasms
23
Lung Neoplasms
17
Breast Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Stomach Neoplasms
10
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Neoplasms
8
Urinary Bladder Neoplasms
6
Carcinoma, Transitional Cell
6
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Neoplasm Metastasis
5
Head and Neck Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Endometrial Neoplasms
4
Small Cell Lung Carcinoma
3
Salivary Gland Neoplasms
3
Nasopharyngeal Carcinoma
3
Laryngeal Neoplasms
3
HER2-positive Breast Cancer
3
Fallopian Tube Neoplasms
3
Anatomic Stage I Breast Cancer AJCC v8
3
Adenocarcinoma
3
Solid Tumors
2
Sarcoma
2
Osteosarcoma
2
Interventions
pembrolizumab
2
durvalumab
2
Tretinoin
2
Paclitaxel
2
Oxaliplatin
2
Irinotecan
2
Chemoradiotherapy
2
Carboplatin
2
Capecitabine
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
relugolix
1
pexidartinib
1
pertuzumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
enzalutamide
1
dostarlimab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Docetaxel
×
90 days
×
Clear all
No trials found.